Omicron variant study could contribute to future vaccine development

  • December 13, 2022
Omicron variant study could contribute to future vaccine development

Antonia Netzl is co-author of a study on Covid variants which has implications for vaccine development

Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants.

Antonia Netzl et al

All the omicron strains are different from the original COVID infection and from each other, but repeated exposure to pre-omicron variants can protect against omicron variants, according to a new study which has implications for further vaccine development.

The study, BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants, is published in Nature Communications today and is co-authored by Gates Cambridge Scholar Antonia Netzl.

It looked at the original omicron variant [BA.1] and sought to compare whether the BA.2 and BA.5 sub-variants which soon replaced it in many countries were more resistant to COVID vaccines.

Using people with differing histories of exposure to infection and vaccination, they found that unvaccinated people had limited cross-neutralising antibodies to pre-omicron variants and BA.1 after a single exposure to BA.2.

By mapping all variants of concern and the omicron sub-variants, they showed that all the omicron sub-variants are distinct to pre-omicron variants, but that the three omicron variants are also antigenically distinct from each other.

Moreover, antibodies that can fight the virus are only generated after three or more exposures to antigenically close variants and also after two exposures to antigenically distant variants.

They say: “Our work presents an important contribution to the discussion on vaccine updates to improve protection against current and future emerging SARS-CoV-2 variants. It suggests that cross-neutralisation improves with repeated exposure and an increase in absolute titers of antibodies and that exposure to two distant variants has protective potential against emerging variants with some degree of similarity to currently and previously circulating Variants of Concern.”

*Picture credit: https://www.vperemen.comCC BY-SA 4.0 and Wikimedia Commons.

 

Latest News

First winner of Dr Arif Naveed Education Prize announced

The first Dr Arif Naveed Education Prize, honouring the work and legacy of Gates Cambridge Scholar Arif Naveed, has been awarded to a researcher and columnist from Bangladesh. The £1K […]

Creating a fairer, more inclusive healthcare system for children

Lengwe Sinkala [2026] is a doctor with a keen interest in how health systems can be improved, particularly for neurodivergent children. She spent Covid working on the frontline in a […]

How to lead in a 24/7 media environment

Two Gates Cambridge Scholars debate how to lead in a 24/7 media environment in the latest edition of the So, now what? Gates Cambridge podcast. Stephen Lezak [2019] and Ben […]

Combining fundamental Physics and start-up leadership

Viviana Gomez Ramirez [2026] likes to focus on the big questions in Physics, seeing it as a form of Philosophy. Her PhD, which she starts in the autumn, aims to […]